"Cross Protection" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Protection conferred on a host by inoculation with one strain or component of a microorganism that prevents infection when later challenged with a similar strain. Most commonly the microorganism is a virus.
| Descriptor ID |
D056738
|
| MeSH Number(s) |
G12.450.275
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cross Protection".
Below are MeSH descriptors whose meaning is more specific than "Cross Protection".
This graph shows the total number of publications written about "Cross Protection" by people in this website by year, and whether "Cross Protection" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 0 | 1 | 1 |
| 2017 | 1 | 1 | 2 |
| 2019 | 0 | 2 | 2 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cross Protection" by people in Profiles.
-
Developing a low-cost and accessible COVID-19 vaccine for global health. PLoS Negl Trop Dis. 2020 07; 14(7):e0008548.
-
Challenging immunodominance of influenza-specific CD8+ T cell responses restricted by the risk-associated HLA-A*68:01 allomorph. Nat Commun. 2019 12 06; 10(1):5579.
-
ILC2s mediate systemic innate protection by priming mucus production at distal mucosal sites. J Exp Med. 2019 12 02; 216(12):2714-2723.
-
Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody. Sci Transl Med. 2017 04 05; 9(384).
-
Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A viruses. Antiviral Res. 2017 05; 141:62-72.
-
Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type. J Infect Dis. 2015 May 15; 211(10):1529-40.
-
A replicating modified vaccinia tiantan strain expressing an avian-derived influenza H5N1 hemagglutinin induce broadly neutralizing antibodies and cross-clade protective immunity in mice. PLoS One. 2013; 8(12):e83274.
-
Broadly neutralizing DNA vaccine with specific mutation alters the antigenicity and sugar-binding activities of influenza hemagglutinin. Proc Natl Acad Sci U S A. 2011 Mar 01; 108(9):3510-5.
-
How did the 2008-2009 seasonal influenza vaccine affect the pandemic? Clin Infect Dis. 2010 Dec 15; 51(12):1380-2.